Familial Hypercholesterolaemia is a common genetic disorder, manifested by elevated levels of LDL-cholesterol in the blood.
Individuals with this pathology are considered high cardiovascular risk patients, as they often present with cardiovascular diseases at an early age (<55 years), such as myocardial infarction and stroke.
Lipid inCode analyses the genes of interest linked to Familial Hypercholesterolaemia, Autosomal Recessive Hypercholesterolaemia and Lysosomal Acid Lipase Deficiency, and characterises them at the functional level.
In case one or more genetic variants of interest have been identified in the first person of a family to be tested (called Index Case), it is always recommended to perform a familial cascade diagnosis.
Familial testing for the diagnosis of Familial Hypercholesterolaemia 200 €
Read more about the Lipid inCode genetic study
